Transthyretin Amyloid Polyneuropathy (ATTR-PN)
1 clinical trials · Condition
◉ Watch Transthyretin Amyloid Polyneuropathy (ATTR-PN)
| Record | Firm | Date |
|---|---|---|
| The Effect Of Tafamidis Meglumine In Transthyretin Amyloid Polyneuropathy Patients (NCT04828993) | Pfizer | 2021-04-28 |
Track Transthyretin Amyloid Polyneuropathy (ATTR-PN) automatically
Every clearance here is in the API, with alerts when new ones post.